SG11201901250PA - Methods and compositions for the treatment of warts - Google Patents

Methods and compositions for the treatment of warts

Info

Publication number
SG11201901250PA
SG11201901250PA SG11201901250PA SG11201901250PA SG11201901250PA SG 11201901250P A SG11201901250P A SG 11201901250PA SG 11201901250P A SG11201901250P A SG 11201901250PA SG 11201901250P A SG11201901250P A SG 11201901250PA SG 11201901250P A SG11201901250P A SG 11201901250PA
Authority
SG
Singapore
Prior art keywords
compositions
international
pennsylvania
pct
warts
Prior art date
Application number
SG11201901250PA
Other languages
English (en)
Inventor
Stuart D Shanler
Christopher Powala
Christopher Phillips
Brian Beger
Evans Charles Rodney Greenaway
Marc Barry Brown
Original Assignee
Aclaris Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aclaris Therapeutics Inc filed Critical Aclaris Therapeutics Inc
Publication of SG11201901250PA publication Critical patent/SG11201901250PA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11201901250PA 2016-08-17 2017-08-17 Methods and compositions for the treatment of warts SG11201901250PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662376326P 2016-08-17 2016-08-17
PCT/US2017/047350 WO2018035328A1 (en) 2016-08-17 2017-08-17 Methods and compositions for the treatment of warts

Publications (1)

Publication Number Publication Date
SG11201901250PA true SG11201901250PA (en) 2019-03-28

Family

ID=61190995

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201901250PA SG11201901250PA (en) 2016-08-17 2017-08-17 Methods and compositions for the treatment of warts

Country Status (13)

Country Link
US (1) US20180050009A1 (zh)
EP (1) EP3500274A4 (zh)
JP (1) JP2019524837A (zh)
KR (1) KR20190039575A (zh)
CN (1) CN109862898A (zh)
AU (1) AU2017312047A1 (zh)
BR (1) BR112019003271A2 (zh)
CA (1) CA3033669A1 (zh)
MX (1) MX2019001838A (zh)
RU (1) RU2019107362A (zh)
SG (1) SG11201901250PA (zh)
WO (1) WO2018035328A1 (zh)
ZA (1) ZA201900984B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201608775XA (en) 2014-04-21 2016-11-29 Aclaris Therapeutics Inc Peroxide formulations and methods and applicators for using the same
US20210196676A1 (en) * 2018-05-30 2021-07-01 The Board Of Regents Of The University Of Texas System Treatment of viral infections and virally associated lesions with sequiterpene lactones
CN111249306A (zh) * 2020-01-16 2020-06-09 刘贤贤 一种去除角质的药物及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5958984A (en) * 1996-10-10 1999-09-28 Devillez; Richard L. Method and composition for skin treatment
US6028104A (en) * 1997-01-30 2000-02-22 Ecolab Inc. Use of peroxygen compounds in the control of hairy wart disease
US20040101571A1 (en) * 2002-09-11 2004-05-27 Pamela Reed Use of hydrogen peroxide for the treatment of warts
US20080206161A1 (en) * 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
SG11201608775XA (en) * 2014-04-21 2016-11-29 Aclaris Therapeutics Inc Peroxide formulations and methods and applicators for using the same

Also Published As

Publication number Publication date
MX2019001838A (es) 2019-06-13
WO2018035328A1 (en) 2018-02-22
EP3500274A4 (en) 2020-08-12
BR112019003271A2 (pt) 2019-06-04
KR20190039575A (ko) 2019-04-12
ZA201900984B (en) 2019-12-18
RU2019107362A (ru) 2020-09-22
JP2019524837A (ja) 2019-09-05
AU2017312047A1 (en) 2019-10-17
CA3033669A1 (en) 2018-02-22
CN109862898A (zh) 2019-06-07
EP3500274A1 (en) 2019-06-26
US20180050009A1 (en) 2018-02-22

Similar Documents

Publication Publication Date Title
SG11201811432WA (en) Rna for cancer therapy
SG11201909949XA (en) Targeted immunotolerance
SG11201808990QA (en) Compositions for topical application of compounds
SG11201900163PA (en) Macrocycle kinase inhibitors
SG11201811230RA (en) Compositions and methods for reducing ocular neovascularization
SG11201903061YA (en) Combination treatments comprising administration of imidazopyrazinones
SG11201810280YA (en) Spiro-lactam nmda receptor modulators and uses thereof
SG11201900349VA (en) Somatostatin modulators and uses thereof
SG11201805001UA (en) Method of treating influenza a
SG11201900551WA (en) Spiro-lactam nmda receptor modulators and uses thereof
SG11201900546UA (en) Spiro-lactam and bis-spiro-lactam nmda receptor modulators and uses thereof
SG11201808222RA (en) Methods of treatment of cholestatic diseases
SG11201900554YA (en) Spiro-lactam nmda modulators and methods of using same
SG11201900558RA (en) Spiro-lactam nmda receptor modulators and uses thereof
SG11201901063SA (en) Therapeutic agents for neurodegenerative diseases
SG11201901534VA (en) Combination therapy with controlled-release cnp agonists
SG11201903076QA (en) Carbamoyl phenylalaninol compounds and uses therof
SG11201811351WA (en) Compositions and methods for forming stable, liquid metal oxide/hydroxide formulations
SG11201901048VA (en) Pharmaceutical compositions and uses directed to lysosomal storage disorders
SG11201903770UA (en) Combination treatments comprising imidazopyrazinones for the treatment of psychiatric and/or cognitive disorders
SG11201806480UA (en) Derivatives of pyrroloimidazole or analogues thereof which are useful for the treatment of inter alia cancer
SG11201900361RA (en) Methods of treating prostate cancer
SG11201906557UA (en) Novel stable formulation for fxia antibodies
SG11201809882XA (en) Pharmaceutical combinations for treating cancer
SG11201901250PA (en) Methods and compositions for the treatment of warts